by Administrator | Dec 22, 2015 | blog, HIV Treatment
Curant COO, Marc O’Connor, was recently featured in Specialty Pharmacy Times in a piece that highlights the futility of presidential candidates focusing strictly on pharmaceutical manufacturers as the primary source of healthcare’s woes. It is true that companies such...
by Administrator | Dec 10, 2015 | blog
As 2015 winds down, this would be an opportune time to look at learnings from the last year within the healthcare industry, as well as the future insights from healthcare stakeholders. Curant Health COO, Marc O’Connor, gives his insights on developments providers,...
by Administrator | Oct 6, 2015 | blog
All healthcare stakeholders are aware the day is coming when pharma manufacturers will need to go at-risk in order to secure inclusion of their high-cost drugs in plan formularies. This shouldn’t be viewed as simply a unilateral opportunity to force price concessions...
Recent Comments